T1	Participants 77 120	patients with breast and colorectal cancer.
T2	Participants 532 592	patients with cancer during adjuvant chemotherapy treatment.
T3	Participants 827 919	patients with breast cancer (BRCA) and colorectal cancer (CRC) during adjuvant chemotherapy.
T4	Participants 1093 1105	participants
T5	Participants 1160 1172	participants
T6	Participants 1355 1367	participants
T7	Participants 1526 1545	intervention group.
T8	Participants 1746 1764	intervention group
T9	Participants 1783 1797	control group.
T10	Participants 1969 1987	intervention group
